Prof Merav Leiba


Director of the Hematology Institute at Assuta Ashdod Public Hospital. She is an expert in internal medicine and hematology. Graduate of the Technion School of Medicine with honors.

She specialized in internal medicine and hematology at Sheba Hospital, Tel Hashomer. After completing her internship in hematology, she was awarded a research scholarship to Harvard University, partnering in a number of important studies, one of which led to the development of a new treatment protocol for multiple myeloma (allotuzumab).

Prof  Leiba has participated in and led many international clinical trials and published over 40 articles in leading medical journals.